|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1.6900 - 2.5000|
|52 Week Range||1.6100 - 5.0000|
|Beta (3Y Monthly)||0.99|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
For MDxHealth SA’s (ENXTBR:MDXH) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. The beta measures MDXH’sRead More...
In this article, I’m going to take a look at MDxHealth SA’s (ENXTBR:MDXH) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors.Read More...
MDxHealth SA’s (ENXTBR:MDXH): MDxHealth SA, a molecular diagnostics company, develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients in Belgium and internationally.Read More...